Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
QIWI plc ADR

Start price
Target price
Perf. (%)
€9.34
12.03.21
€11.00
12.03.22
-3.10%
01.07.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Dataproces Group A/s

Start price
Target price
Perf. (%)
€1.28
12.03.21
€1.55
12.03.22
-37.19%
12.03.22

Could be worthwhile Investment >10% per year
Known brand
Future proof or reliable business model
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€16.00
12.03.21
€22.00
12.03.22
-62.19%
12.08.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€57.58
12.03.21
-
08.03.22
-42.45%
24.03.21

Risky Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Little Investments for future growth
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€13.28
12.03.21
€24.00
12.03.22
-62.26%
12.03.22

Could be very worthwhile Investment >20% year
buy
TAAT Global Alternatives Inc.

Start price
Target price
Perf. (%)
€2.80
12.03.21
€5.00
12.03.22
-63.04%
12.03.22

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Ether Capital Corp.

Start price
Target price
Perf. (%)
€2.06
11.03.21
-
11.03.22
0.00%
09.07.21

Revenue growth > 30% per year expected
EBIT decline > 20% expected
Probably not worthwhile Investment
buy
Match Group Inc old

Start price
Target price
Perf. (%)
€94.85
11.03.21
€105.00
-
18.03.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Strong uniques
buy
Sfc Energy AG

Start price
Target price
Perf. (%)
€24.85
11.03.21
€28.00
11.03.22
18.11%
12.03.22

Could be worthwhile Investment >10% per year
buy
Telefónica Deutschland Holding AG

Start price
Target price
Perf. (%)
€2.37
11.03.21
€3.00
11.06.21
5.12%
21.05.21

Very high dividend yield expected
Undervalued
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€223.85
11.03.21
-
11.03.22
29.77%
21.12.21

buy
International Paper

Start price
Target price
Perf. (%)
€45.81
10.03.21
-
10.03.22
-15.86%
11.03.22

Very high dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bilibili Inc.

Start price
Target price
Perf. (%)
€86.50
10.03.21
-
10.03.22
7.51%
20.03.21

Northern Data AG

Start price
Target price
Perf. (%)
€100.00
10.03.21
-
10.03.22
-0.80%
20.03.21

AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€8.65
10.03.21
-
10.03.22
32.95%
20.03.21

Gamestop Corp.

Start price
Target price
Perf. (%)
€52.34
10.03.21
-
10.03.22
-18.09%
20.03.21

High risks for its business
Outdated or very high risk business model
buy
BP plc

Start price
Target price
Perf. (%)
€3.68
10.03.21
-
10.03.22
19.06%
11.03.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
Gamestop Corp.

Start price
Target price
Perf. (%)
€51.45
10.03.21
-
08.03.22
11.90%
12.03.21

Risky Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Little Investments for future growth
buy
Fermentalg S.A.

Start price
Target price
Perf. (%)
€3.25
10.03.21
€3.50
10.03.22
-0.92%
11.11.21

buy
PVA TePla AG

Start price
Target price
Perf. (%)
€22.75
10.03.21
€45.50
22.04.23
10.11%
03.05.21

Small Risks for its business
Could be very worthwhile Investment >20% year
MTU Aero Engines AG

Start price
Target price
Perf. (%)
€204.20
10.03.21
€170.00
10.03.22
-3.55%
11.03.22

Some uniques
Probably not worthwhile Investment
Low dividend yield expected
overvalued
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€26.55
10.03.21
-
10.03.22
-86.89%
11.03.22

Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Altamira Therapeutics Ltd.

Start price
Target price
Perf. (%)
€3.98
10.03.21
-
10.03.22
-74.62%
11.03.22

Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

buy
Deutsche Bank AG

Start price
Target price
Perf. (%)
€10.81
10.03.21
€12.00
1.57%
18.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group